Department of Otolaryngology-Head and Neck Surgery, Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan.
Department of Otorhinolaryngology, College of Medicine, Konyang University.
Otol Neurotol. 2018 Dec;39(10):e950-e955. doi: 10.1097/MAO.0000000000002023.
To analyze risk factors for acute low-frequency hearing loss (ALFHL), and compare treatment outcomes in the presence or absence of such risk factors.
A case series featuring retrospective chart review.
An academic university hospital.
We included 170 ALFHL patients without vertigo. All of the patients received one of four treatments: low-dose steroid (LD-steroid), high-dose steroid (HD-steroid), LD-steroid and diuretics (LD-combination therapy), and ITDI (intratympanic dexamethasone injection) and diuretics (ITDI-combination therapy). To identify risk factors, we reviewed the clinical features of patients such as age, sex, chief complaint, accompanying symptoms, diabetes, hypertension, time from disease onset, the extent of hearing loss, treatment methods, and 1 kHz involvement.
ALFHL was diagnosed based on the average hearing loss >30 dB at 250 and 500 Hz.
The overall rates of hearing recovery were 70-80% in the four treatment groups. In terms of the prognosis of ALFHL patients, we found that a longer time from disease onset and 1 kHz involvement were independent risk factors for poor prognosis. In addition, we compared treatment outcomes of four treatment methods in the presence or absence of risk factors. In ALFHL patients with risk factors, we found statistically significant differences (p = 0.042) among treatment methods; effectiveness ranged in the order if ITDI-combination therapy, LD-combination therapy, HD-steroid, and LD-steroid.
Risk factors for poor hearing recovery in ALFHL included longer symptom duration and 1 kHz involvement. In ALFHL with such risk factors, combination therapy was more effective than oral steroid therapy.
分析急性低频感音神经性听力损失(ALFHL)的危险因素,并比较存在或不存在这些危险因素时的治疗效果。
回顾性病例系列研究。
学术大学医院。
我们纳入了 170 例无眩晕的 ALFHL 患者。所有患者均接受了以下四种治疗之一:低剂量类固醇(LD-steroid)、高剂量类固醇(HD-steroid)、LD-类固醇和利尿剂(LD-combination therapy)以及鼓室内地塞米松注射和利尿剂(ITDI- combination therapy)。为了确定危险因素,我们回顾了患者的临床特征,如年龄、性别、主要诉求、伴随症状、糖尿病、高血压、发病时间、听力损失程度、治疗方法以及 1kHz 受累情况。
根据 250 和 500Hz 平均听力损失>30dB 诊断 ALFHL。
四组治疗的听力恢复总体率为 70-80%。就 ALFHL 患者的预后而言,我们发现发病时间较长和 1kHz 受累是预后不良的独立危险因素。此外,我们比较了存在或不存在危险因素时四种治疗方法的治疗效果。在有危险因素的 ALFHL 患者中,我们发现治疗方法之间存在显著差异(p=0.042);有效性按 ITDI- combination therapy、LD- combination therapy、HD-steroid 和 LD-steroid 的顺序排列。
ALFHL 听力恢复不良的危险因素包括症状持续时间较长和 1kHz 受累。在有这些危险因素的 ALFHL 中,联合治疗比口服类固醇治疗更有效。